Biocompatible Coating

Comprehensive Materials Processing

Volumn 4, Issue , 2014, Pages 425-447

  Qiao, Y ^a   Liu, X ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Antibacterial activity; Biocompatibility; Biological responses; Biomaterials; Cytocompatibility; Cytotoxicity; Hemocompatibility; Immunocompatibility; Inflammatory response; Nonthrombogenic property; Protein adsorption

Indexed keywords

BIOCOMPATIBILITY; BIOMATERIALS; CYTOTOXICITY; TISSUE;

ANTI-BACTERIAL ACTIVITY; BIOLOGICAL RESPONSE; CYTOCOMPATIBILITY; HEMOCOMPATIBILITY; IMMUNOCOMPATIBILITY; INFLAMMATORY RESPONSE; NONTHROMBOGENIC PROPERTY; PROTEIN ADSORPTION;

COATINGS;

EID: 84903499939     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-096532-1.00418-0     Document Type: Chapter

References (381)

1. Peppas N.A., Langer R. New Challenges in Biomaterials. Science 1994, 263(5154):1715-1720.
2. Huebsch N., Mooney D.J. Inspiration and Application in the Evolution of Biomaterials. Nature 2009, 462(7272):426-432.
3. Williams D.F. Definitions in Biomaterials. Proceedings of a Consensus Conference of the European Society for Biomaterials, England 1987, Vol. 4. Elsevier, New York.
4. Helmus M.N., Gibbons D.F., Cebon D. Biocompatibility: Meeting a Key Functional Requirement of Next-Generation Medical Devices. Toxicol. Pathol. 2008, 36(1):70-80.
5. Williams D.F. On the Mechanisms of Biocompatibility. Biomaterials 2008, 29(20):2941-2953.
6. Ratner B.D. New Ideas in Biomaterials Science - A Path to Engineered Biomaterials. J. Biomed. Mater. Res. 1993, 27(7):837-850.
7. Hench L.L., Wilson J. Surface-Active Biomaterials. Science 1984, 226(4675):630-636.
8. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M.V., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface. Nat. Mater. 2009, 8(7):543-557.
9. Klee D., Hocker H. Polymers for Biomedical Applications: Improvement of the Interface Compatibility. Adv. Polym. Sci. 1999, 149:1-57.
10. Spector M. The Concept of Biocompatibility. Comprehensive Biomaterials 2011, Vol. 4. (chapter 4.401), Elsevier Ltd., Amsterdam, Boston. P. Ducheyne, K.E. Healy, D.W. Hutmacher, D.W. Grainger, C.J. Kirkpatrick (Eds.).
11. Anderson J., McNally A. Biocompatibility of Implants: Lymphocyte/Macrophage Interactions. Semin. Immunopathol. 2011, 33(3):221-233.
12. Fournier E., Passirani C., Montero-Menei C.N., Benoit J.P. Biocompatibility of Implantable Synthetic Polymeric Drug Carriers: Focus on Brain Biocompatibility. Biomaterials 2003, 24(19):3311-3331.
13. Anderson J.M. Biological Responses to Materials. Annu. Rev. Mater. Res. 2001, 31:81-110.
14. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune Responses to Implants - A Review of the Implications for the Design of Immunomodulatory Biomaterials. Biomaterials 2011, 32(28):6692-6709.
15. Anderson J.M., Rodriguez A., Chang D.T. Foreign Body Reaction to Biomaterials. Semin. Immunol. 2008, 20(2):86-100.
16. Murphy H.S. Inflammation. Rubin's Pathology: Clinicopathologic Foundations of Medicine 2008, Vol. 3:37-70. (chapter 3), Lippincott Williams & Wilkins. 5th ed. R. Rubin, D.S. Strayer (Eds.).
17. Horbett T.A. Host Reactions to Biomaterials and Their Evaluation. Biomaterials Science: An Introduction to Materials in Medicine 2004, 293-354. (chapter 4), Elsevier Academic Press, San Diego. 2nd ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
18. Gorbet M.B., Sefton M.V. Biomaterial-Associated Thrombosis: Roles of Coagulation Factors, Complement, Platelets and Leukocytes. Biomaterials 2004, 25(26):5681-5703.
19. Sivaraman B., Fears K.P., Latour R.A. Investigation of the Effects of Surface Chemistry and Solution Concentration on the Conformation of Adsorbed Proteins Using an Improved Circular Dichroism Method. Langmuir 2009, 25(5):3050-3056.
20. Roach P., Farrar D., Perry C.C. Interpretation of Protein Adsorption: Surface-Induced Conformational Changes. J. Am. Chem. Soc. 2005, 127(22):8168-8173.
21. Pascual A. Pathogenesis of Catheter-Related Infections: Lessons for New Designs. Clin. Microbiol. Infect. 2002, 8(5):256-264.
22. Katsikogianni M., Missirlis Y.F. Concise Review of Mechanisms of Bacterial Adhesion to Biomaterials and of Techniques Used in Estimating Bacteria-Material Infections. Eur. Cells Mater. 2004, 8:37-57.
23. Donlan R.M., Costerton J.W. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clin. Microbiol. Rev. 2002, 15(2):167-193.
24. Martinez J.L., Baquero F. Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance. Clin. Microbiol. Rev. 2002, 15(4):647-679.
25. Ratner B.D. The Catastrophe Revisited: Blood Compatibility in the 21st Century. Biomaterials 2007, 28(34):5144-5147.
26. Eberhart R.C., Clagett C.P. Catheter Coatings, Blood-Flow, and Biocompatibility. Semin. Hematol. 1991, 28(4):42-48.
27. Schaadt J. Oxygenator Thrombosis: An International Phenomenon. Perfusion 1999, 14(6):425-435.
28. Belway D., Rubens F.D. Currently Available Biomaterials for Use in Cardiopulmonary Bypass. Expert Rev. Med. Devices 2006, 3(3):345-355.
29. Liu Z., Jiao Y., Wang T., Zhang Y., Xue W. Interactions between Solubilized Polymer Molecules and Blood Components. J. Controlled Release 2012, 160:11.
30. Deppisch R., Storr M., Buck R., Gohl H. Blood Material Interactions at the Surfaces of Membranes in Medical Applications. Sep. Purif. Technol. 1998, 14(1-3):241-254.
31. Hoffman A.S. Blood-Biomaterial Interactions: An Overview. Biomaterials: Interfacial Phenomena and Applications. Advances in Chemistry Series 1982, Vol. 199:3-8. American Chemical Society, Washington. S.L. Cooper, N.A. Peppas, A.S. Hoffman, B.D. Ratner (Eds.).
32. Dee K.C., Puleo D.A., Bizios R. Biomaterials, Devices, and Thrombosis. An Introduction to Tissue-Biomaterial Interactions 2002, 81-85. (chapter 4.7), John Wiley & Sons, Inc., New York.
33. Werner C., Maitz M.F., Sperling C. Current Strategies towards Hemocompatible Coatings. J. Mater. Chem. 2007, 17(32):3376-3384.
34. Keefer L.K. Biomaterials - Thwarting Thrombus. Nat. Mater. 2003, 2(6):357-358.
35. Noh H., Vogler E.A. Volumetric Interpretation of Protein Adsorption: Competition from Mixtures and the Vroman Effect. Biomaterials 2007, 28(3):405-422.
36. Horbett T.A. The Role of Adsorbed Proteins in Tissue Response to Biomaterials. Biomaterials Science: An Introduction to Materials in Medicine 2004, 237-245. Elsevier Academic Press, San Diego. 2nd ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
37. Vogler E.A., Siedlecki C.A. Contact Activation of Blood-Plasma Coagulation. Biomaterials 2009, 30(10):1857-1869.
38. Furie B., Furie B.C. The Molecular-Basis of Blood-Coagulation. Cell 1988, 53(4):505-518.
39. Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and Coagulation: Strangers or Partners in Crime?. Trends Immunol. 2007, 28(4):184-192.
40. Granada J.F., Price M.J., French P.A., Steinhubl S.R., Cutlip D.E., Becker R.C., Smyth S.S., Dauerman H.L. Platelet-Mediated Thrombosis and Drug-Eluting Stents. Circ. Cardiovasc. Interventions 2011, 4(6). 629-637.
41. Monroe D., Hoffman M., Roberts H.R. Platelets and Thrombin Generation. Arterioscler. Thromb. Vasc. Biol. 2002, 22(9):1381-1389.
42. Sperling C., Fischer M., Maitz M.F., Werner C. Blood Coagulation on Biomaterials Requires the Combination of Distinct Activation Processes. Biomaterials 2009, 30(27):4447-4456.
43. Seyfert U.T., Biehl V., Schenk J. In Vitro Hemocompatibility Testing of Biomaterials According to the ISO 10993-4. Biomol. Eng. 2002, 19(2-6):91-96.
44. Hlady V., Buijs J. Protein Adsorption on Solid Surfaces. Curr. Opin. Biotech. 1996, 7(1):72-77.
45. Dee K.C., Puleo D.A., Bizios R. Protein-Surface Interactions. An Introduction to Tissue-Biomaterial Interactions 2002, 37-52. John Wiley & Sons, Inc., New York.
46. Zhuo R., Siedlecki C.A., Vogler E.A. Autoactivation of Blood Factor XII at Hydrophilic and Hydrophobic Surfaces. Biomaterials 2006, 27(24):4325-4332.
47. Golas A., Parhi P., Dimachkie Z.O., Siedlecki C.A., Vogler E.A. Surface-Energy Dependent Contact Activation of Blood Factor XII. Biomaterials 2010, 31(6):1068-1079.
48. Hanson S.R. Blood Coagulation and Blood Material Interactions. Biomaterials Science: An Introduction to Materials in Medicine 2002, 332-337. Elsevier Academic Press, San Diego. 2nd ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
49. Dee K.C., Puleo D.A., Bizios R. The Coagulation Cascades. An Introduction to Tissue-Biomaterial Interactions 2002, 73-79. John Wiley & Sons, Inc., New York.
50. Schmaier A.H. Plasma Kallikrein/Kinin System: A Revised Hypothesis for Its Activation and Its Physiologic Contributions. Curr. Opin. Hematol. 2000, 7(5):261-265.
51. Davie E.W., Fujikawa K., Kisiel W. The Coagulation Cascade - Initiation, Maintenance, and Regulation. Biochemistry 1991, 30(43):10363-10370.
52. Zhuo R., Siedlecki C.A., Vogler E.A. Competitive-Protein Adsorption in Contact Activation of Blood Factor XII. Biomaterials 2007, 28(30):4355-4369.
53. Mackman N. Triggers, Targets and Treatments for Thrombosis. Nature 2008, 451(7181):914-918.
54. Ruggeri Z.M. Mechanisms Initiating Platelet Thrombus Formation. Thromb. Haemostasis 1997, 78(1):611-616.
55. Ruggeri Z.M. Role of von Willebrand Factor in Platelet Thrombus Formation. Ann. Med. 2000, 32:2-9.
56. Weiss H.J., Hawiger J., Ruggeri Z.M., Turitto V.T., Thiagarajan P., Hoffmann T. Fibrinogen-Independent Platelet-Adhesion and Thrombus Formation on Subendothelium Mediated by Glycoprotein IIb-IIIa Complex at High Shear Rate. J. Clin. Invest. 1989, 83(1):288-297.
57. Sivaraman B., Latour R.A. The Relationship between Platelet Adhesion on Surfaces and the Structure versus the Amount of Adsorbed Fibrinogen. Biomaterials 2010, 31(5):832-839.
58. Zaidi T.N., McIntire L.V., Farrell D.H., Thiagarajan P. Adhesion of Platelets to Surface-Bound Fibrinogen under Flow. Blood 1996, 88(8):2967-2972.
59. Andersen H., Greenberg D.L., Fujikawa K., Xu W.F., Chung D.W., Davie E.W. Protease-Activated Receptor 1 is the Primary Mediator of Thrombin-Stimulated Platelet Procoagulant Activity. Proc. Natl. Acad. Sci. U. S. A 1999, 96(20):11189-11193.
60. Furie B., Furie B.C. Mechanisms of Thrombus Formation. N. Engl. J. Med. 2008, 359(9):938-949.
61. Brass L.F. Thrombin and Platelet Activation. Chest 2003, 124(3):18s-25s.
62. Ekdahl K.N., Lambris J.D., Elwing H., Ricklin D., Nilsson P.H., Teramura Y., Nicholls I.A., Nilsson B. Innate Immunity Activation on Biomaterial Surfaces: A Mechanistic Model and Coping Strategies. Adv. Drug Delivery Rev. 2011, 63(12):1042-1050.
63. Engberg A.E., Rosengren-Holmberg J.P., Chen H., Nilsson B., Lambris J.D., Nicholls I.A., Ekdahl K.N. Blood Protein-Polymer Adsorption: Implications for Understanding Complement-Mediated Hemoincompatibility. J. Biomed. Mater. Res. A 2011, 97A(1):74-84.
64. Hulander M., Lundgren A., Berglin M., Ohrlander M., Lausmaa J., Elwing H. Immune Complement Activation is Attenuated by Surface Nanotopography. Int. J. Nanomed. 2011, 6:2653-2666.
65. Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. The Role of Complement in Biomaterial-Induced Inflammation. Mol. Immunol. 2007, 44(1-3):82-94.
66. Marceau F., Hugli T.E. Effect of C3a and C5a Anaphylatoxins on Guinea-Pig Isolated Blood-Vessels. J. Pharmacol. Exp. Ther. 1984, 230(3):749-754.
67. Nilsson B., Korsgren O., Lambris J.D., Ekdahl K.N. Can Cells and Biomaterials in Therapeutic Medicine be Shielded from Innate Immune Recognition?. Trends Immunol. 2010, 31(1):32-38.
68. de Mel A., Cousins B.G., Seifalian A.M. Surface Modification of Biomaterials: A Quest for Blood Compatibility. Int. J. Biomater. 2012, 707863.
69. Li S., Henry J.J.D. Nonthrombogenic Approaches to Cardiovascular Bioengineering. Annu. Rev. Biomed. Eng. 2011, 13:451-475.
70. Schopka S., Schmid T., Schmid C., Lehle K. Current Strategies in Cardiovascular Biomaterial Functionalization. Materials 2010, 3(1):638-655.
71. Chiang Y.C., Chang Y., Higuchi A., Chen W.Y., Ruaan R.C. Sulfobetaine-Grafted Poly(Vinylidene Fluoride) Ultrafiltration Membranes Exhibit Excellent Antifouling Property. J. Membrane. Sci. 2009, 339(1-2):151-159.
72. Langer R., Tirrell D.A. Designing Materials for Biology and Medicine. Nature 2004, 428(6982):487-492.
73. Goodman S.L., Tweden K.S., Albrecht R.M. Platelet Interaction with Pyrolytic Carbon Heart-Valve Leaflets. J. Biomed. Mater. Res. 1996, 32(2):249-258.
74. Yu L.J., Wang X., Wang X.H., Liu X.H. Haemocompatibility of Tetrahedral Amorphous Carbon Films. Surf. Coat. Technol. 2000, 128:484-488.
75. Yang P., Kwok S.C.H., Chu P.K., Leng Y.X., Chen J.Y., Wang J., Huang N. Haemocompatibility of Hydrogenated Amorphous Carbon (a-C: H) Films Synthesized by Plasma Immersion Ion Implantation-Deposition. Nucl. Instrum. Methods Phys. Res. B 2003, 206:721-725.
76. Gutensohn K., Beythien C., Bau J., Fenner T., Grewe P., Koester R., Padmanaban K., Kuehnl P. In Vitro Analyses of Diamond-Like Carbon Coated Stents: Reduction of Metal Ion Release, Platelet Activation, and Thrombogenicity. Thromb. Res. 2000, 99(6):577-585.
77. Fedel M., Motta A., Maniglio D., Migliaresi C. Surface Properties and Blood Compatibility of Commercially Available Diamond-Like Carbon Coatings for Cardiovascular Devices. J. Biomed. Mater. Res. B 2009, 90B(1):338-349.
78. Robertson J. Diamond-Like Amorphous Carbon. Mater. Sci. Eng. R 2002, 37(4-6):129-281.
79. Bolz A., Schaldach M. Artificial Heart Valves: Improved Blood Compatibility by PECVD a-SiC: H Coating. Artif. Organs 1990, 14(4):260-269.
80. Roy R.K., Choi H.W., Yi J.W., Moon M.W., Lee K.R., Han D.K., Shin J.H., Kamijo A., Hasebe T. Hemocompatibility of Surface-Modified, Silicon-Incorporated, Diamond-Like Carbon Films. Acta Biomater. 2009, 5(1):249-256.
81. Roy R.K., Choi H.W., Park S.J., Lee K.R. Surface Energy of the Plasma Treated Si Incorporated Diamond-Like Carbon Films. Diam. Relat. Mater. 2007, 16(9):1732-1738.
82. Saito T., Hasebe T., Yohena S., Matsuoka Y., Kamijo A., Takahashi K., Suzuki T. Antithrombogenicity of Fluorinated Diamond-Like Carbon Films. Diam. Relat. Mater. 2005, 14(3-7):1116-1119.
83. Hasebe T., Shimada A., Suzuki T., Matsuoka Y., Saito T., Yohena S., Kamijo A., Shiraga N., Higuchi M., Kimura K., Yoshimura H., Kuribayashi S. Fluorinated Diamond-Like Carbon as Antithrombogenic Coating for Blood-Contacting Devices. J. Biomed. Mater. Res. A 2006, 76A(1):86-94.
84. Hasebe T., Yohena S., Kamijo A., Okazaki Y., Hotta A., Takahashi K., Suzuki T. Fluorine Doping into Diamond-Like Carbon Coatings Inhibits Protein Adsorption and Platelet Activation. J. Biomed. Mater. Res. A 2007, 83A(4):1192-1199.
85. Hasebe T., Ishimaru T., Kamijo A., Yoshimoto Y., Yoshimura T., Yohena S., Kodama H., Hotta A., Takahashi K., Suzuki T. Effects of Surface Roughness on Anti-Thrombogenicity of Diamond-Like Carbon Films. Diam. Relat. Mater. 2007, 16(4-7):1343-1348.
86. Kwok S.C.H., Jin W., Chu P.K. Surface Energy, Wettability, and Blood Compatibility Phosphorus Doped Diamond-Like Carbon Films. Diam. Relat. Mater. 2005, 14(1):78-85.
87. Kwok S.C.H., Yang P., Wang J., Liu X.Y., Chu P.K. Hemocompatibility of Nitrogen-Doped, Hydrogen-Free Diamond-Like Carbon Prepared by Nitrogen Plasma Immersion Ion Implantation-Deposition. J. Biomed. Mater. Res. A 2004, 70A(1):107-114.
88. Maitz M.F., Gago R., Abendroth B., Camero M., Caretti I., Kreissig U. Hemocompatibility of Low-Friction Boron-Carbon-Nitrogen Containing Coatings. J. Biomed. Mater. Res. B 2006, 77B(1):179-187.
89. Chen J.Y., Leng Y.X., Tian X.B., Wang L.P., Huang N., Chu P.K., Yang P. Antithrombogenic Investigation of Surface Energy and Optical Bandgap and Hemocompatibility Mechanism of Ti(Ta+5)O-2 Thin Films. Biomaterials 2002, 23(12):2545-2552.
90. Okpalugo T.I.T., Ogwu A.A., Maguire P.D., McLaughlin J.A.D. Platelet Adhesion on Silicon Modified Hydrogenated Amorphous Carbon Films. Biomaterials 2004, 25(2):239-245.
91. 3 Doped Diamond-Like Carbon Films. Diam. Relat. Mater. 2008, 17(11):1922-1926.
92. Roy R.K., Lee K.R. Biomedical Applications of Diamond-Like Carbon Coatings: A Review. J. Biomed. Mater. Res. B 2007, 83B(1):72-84.
93. Sunny M.C., Sharma C.P. Titanium-Protein Interaction: Changes with Oxide Layer Thickness. J. Biomater. Appl. 1991, 6(1):89-98.
94. Yang Y., Lai Y.K., Zhang Q.Q., Wu K., Zhang L.H., Lin C.J., Tang P.F. A Novel Electrochemical Strategy for Improving Blood Compatibility of Titanium-Based Biomaterials. Colloids Surf. B 2010, 79(1):309-313.
95. Sun T.L., Tan H., Han D., Fu Q., Jiang L. No Platelet Can Adhere - Largely Improved Blood Compatibility on Nanostructured Superhydrophobic Surfaces. Small 2005, 1(10):959-963.
96. Huang N., Chen Y.R., Luo J.M., Yi J., Lu R., Xiao J., Xue Z.N., Liu X.H. In Vitro Investigation of Blood Compatibility of Ti with Oxide Layers of Rutile Structure. J. Biomater. Appl. 1994, 8(4):404-412.
97. Huang N., Yang P., Leng Y.X., Chen J.Y., Sun H., Wang J., Wang G.J., Ding P.D., Xi T.F., Leng Y. Hemocompatibility of Titanium Oxide Films. Biomaterials 2003, 24(13):2177-2187.
98. 3. J. Mater. Sci. Mater. Med. 2009, 20(10):2019-2023.
99. Zhang F., Liu X.H., Mao Y.J., Huang N., Chen Y., Zheng Z.H., Zhou Z.Y., Chen A.Q., Jiang Z.B. Artificial Heart Valves: Improved Hemocompatibility by Titanium Oxide Coatings Prepared by Ion Beam Assisted Deposition. Surf. Coat. Technol. 1998, 104:146-150.
100. Tsyganov I.A., Maitz M.F., Richter E., Reuther H., Mashina A.I., Rustichelli F. Hemocompatibility of Titanium-Based Coatings Prepared by Metal Plasma Immersion Ion Implantation and Deposition. Nucl. Instrum. Methods Phys. Res. B 2007, 257:122-127.
101. Petersson I.U., Loberg J.E.L., Fredriksson A.S., Ahlberg E.K. Semi-Conducting Properties of Titanium Dioxide Surfaces on Titanium Implants. Biomaterials 2009, 30(27):4471-4479.
102. Chen H., Yuan L., Song W., Wu Z.K., Li D. Biocompatible Polymer Materials: Role of Protein-Surface Interactions. Prog. Polym. Sci. 2008, 33(11):1059-1087.
103. Emmenegger C.R., Brynda E., Riedel T., Sedlakova Z., Houska M., Alles A.B. Interaction of Blood Plasma with Antifouling Surfaces. Langmuir 2009, 25(11):6328-6333.
104. Chen S.F., Li L.Y., Zhao C., Zheng J. Surface Hydration: Principles and Applications toward Low-Fouling/Nonfouling Biomaterials. Polymer 2010, 51(23):5283-5293.
105. Ostuni E., Chapman R.G., Holmlin R.E., Takayama S., Whitesides G.M. A Survey of Structure-Property Relationships of Surfaces that Resist the Adsorption of Protein. Langmuir 2001, 17(18):5605-5620.
106. Chapman R.G., Ostuni E., Takayama S., Holmlin R.E., Yan L., Whitesides G.M. Surveying for Surfaces that Resist the Adsorption of Proteins. J. Am. Chem. Soc. 2000, 122(34):8303-8304.
107. Kingshott P., Griesser H.J. Surfaces that Resist Bioadhesion. Curr. Opin. Solid State Mater. Sci. 1999, 4(4):403-412.
108. Fuertges F., Abuchowski A. The Clinical Efficacy of Poly(Ethylene Glycol)-Modified Proteins. J. Controlled Release 1990, 11(1-3):139-148.
109. Zhang F., Kang E.T., Neoh K.G., Wang P., Tan K.L. Modification of Si(100) Surface by the Grafting of Poly(Ethylene Glycol) for Reduction in Protein Adsorption and Platelet Adhesion. J. Biomed. Mater. Res. 2001, 56(3):324-332.
110. McPherson T.B., Shim H.S., Park K. Grafting of PEO to Glass, Nitinol, and Pyrolytic Carbon Surfaces by Gamma Irradiation. J. Biomed. Mater. Res. 1997, 38(4):289-302.
111. Balakrishnan B., Kumar D.S., Yoshida Y., Jayakrishnan A. Chemical Modification of Poly(Vinyl Chloride) Resin Using Poly(Ethylene Glycol) to Improve Blood Compatibility. Biomaterials 2005, 26(17):3495-3502.
112. Shin H.S., Park K., Kim J.H., Kim J.J., Han D.K., Moon M.W., Lee K.R., Shin J.H. Biocompatible PEG Grafting on DLC-Coated Nitinol Alloy for Vascular Stents. J. Bioact. Compat. Polym. 2009, 24(4):316-328.
113. Hansson K.M., Tosatti S., Isaksson J., Wettero J., Textor M., Lindahl T.L., Tengvall P. Whole Blood Coagulation on Protein Adsorption-Resistant PEG and Peptide Functionalised PEG-Coated Titanium Surfaces. Biomaterials 2005, 26(8):861-872.
114. Gulati N., Rastogi R., Dinda A.M., Saxena R., Koul V. Characterization and Cell Material Interactions of PEGylated PNIPAAM Nanoparticles. Colloids Surf. B 2010, 79(1):164-173.
115. Chen C., Cheng Y.C., Yu C.H., Chan S.W., Cheung M.K., Yu P.H.F. In Vitro Cytotoxicity, Hemolysis Assay, and Biodegradation Behavior of Biodegradable Poly(3-Hydroxybutyrate)-Poly(Ethylene Glycol)-Poly(3-Hydroxybutyrate) Nanoparticles as Potential Drug Carriers. J. Biomed. Mater. Res. A 2008, 87A(2):290-298.
116. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for Imaging and Therapy. Nanomedicine 2011, 6(4):715-728.
117. Knop K., Hoogenboom R., Fischer D., Schubert U.S. Poly(Ethylene Glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. Angew. Chem. Int. Ed. 2010, 49(36):6288-6308.
118. Claesson P. Poly(Ethylene Oxide) Surface-Coatings - Relations between Intermolecular Forces, Layer Structure and Protein Repellency. Colloids Surf. A 1993, 77(2):109-118.
119. Prime K.L., Whitesides G.M. Adsorption of Proteins onto Surfaces Containing End-Attached Oligo(Ethylene Oxide) - A Model System Using Self-Assembled Monolayers. J. Am. Chem. Soc. 1993, 115(23):10714-10721.
120. Harder P., Grunze M., Dahint R., Whitesides G.M., Laibinis P.E. Molecular Conformation in Oligo(Ethylene Glycol)-Terminated Self-Assembled Monolayers on Gold and Silver Surfaces Determines Their Ability to Resist Protein Adsorption. J. Phys. Chem. B 1998, 102(2):426-436.
121. Han D.K., Jeong S.Y., Ahn K.D., Kim Y.H., Min B.G. Preparation and Surface-Properties of Peo-Sulfonate Grafted Polyurethanes for Enhanced Blood Compatibility. J. Biomater. Sci. Polym. Ed. 1993, 4(6):579-589.
122. Szleifer I. Protein Adsorption on Surfaces with Grafted Polymers: A Theoretical Approach. Biophys. J. 1997, 72(2):595-612.
123. Lee J.H., Lee H.B., Andrade J.D. Blood Compatibility of Polyethylene Oxide Surfaces. Prog. Polym. Sci. 1995, 20(6):1043-1079.
124. Malmsten M., Emoto K., Van Alstine J.M. Effect of Chain Density on Inhibition of Protein Adsorption by Poly(Ethylene Glycol) Based Coatings. J. Colloid Interface Sci. 1998, 202(2):507-517.
125. Kingshott P., Thissen H., Griesser H.J. Effects of Cloud-Point Grafting, Chain Length, and Density of PEG Layers on Competitive Adsorption of Ocular Proteins. Biomaterials 2002, 23(9):2043-2056.
126. Pasche S., Voros J., Griesser H.J., Spencer N.D., Textor M. Effects of Ionic Strength and Surface Charge on Protein Adsorption at PEGylated Surfaces. J. Phys. Chem. B 2005, 109(37):17545-17552.
127. Pei J., Hall H., Spencer N.D. The Role of Plasma Proteins in Cell Adhesion to Peg Surface-Density-Gradient-Modified Titanium Oxide. Biomaterials 2011, 32(34):8968-8978.
128. Pasche S., De Paul S.M., Voros J., Spencer N.D., Textor M. Poly(L-Lysine)-Graft-Poly(Ethylene Glycol) Assembled Monolayers on Niobium Oxide Surfaces: A Quantitative Study of the Influence of Polymer Interfacial Architecture on Resistance to Protein Adsorption by ToF-SIMS and In Situ OWLS. Langmuir 2003, 19(22):9216-9225.
129. Jeon S.I., Lee J.H., Andrade J.D., Degennes P.G. Protein Surface Interactions in the Presence of Polyethylene Oxide 1. Simplified Theory. J. Colloid Interface Sci. 1991, 142(1):149-158.
130. Pasche S., Textor M., Meagher L., Spencer N.D., Griesser H.J. Relationship between Interfacial Forces Measured by Colloid-Probe Atomic Force Microscopy and Protein Resistance of Poly(Ethylene Glycol)-Grafted Poly(L-Lysine) Adlayers on Niobia Surfaces. Langmuir 2005, 21(14):6508-6520.
131. Halperin A. Polymer Brushes that Resist Adsorption of Model Proteins: Design Parameters. Langmuir 1999, 15(7):2525-2533.
132. Rixman M.A., Dean D., Ortiz C. Nanoscale Intermolecular Interactions between Human Serum Albumin and Low Grafting Density Surfaces of Poly(Ethylene Oxide). Langmuir 2003, 19(22):9357-9372.
133. Chang Y., Shih Y.J., Ko C.Y., Jhong J.F., Liu Y.L., Wei T.C. Hemocompatibility of Poly(Vinylidene Fluoride) Membrane Grafted with Network-Like and Brush-Like Antifouling Layer Controlled via Plasma-Induced Surface PEGylation. Langmuir 2011, 27(9):5445-5455.
134. Li D., Chen H., McClung W.G., Brash J.L. Lysine-PEG-Modified Polyurethane as a Fibrinolytic Surface: Effect of Peg Chain Length on Protein Interactions, Platelet Interactions and Clot Lysis. Acta Biomater. 2009, 5(6):1864-1871.
135. Wieland B., Lancaster J.P., Hoaglund C.S., Holota P., Tornquist W.J. Electrochemical and Infrared Spectroscopic Quantitative Determination of the Platinum-Catalyzed Ethylene Glycol Oxidation Mechanism at Co Adsorption Potentials. Langmuir 1996, 12(10):2594-2601.
136. Arima Y., Toda M., Iwata H. Complement Activation on Surfaces Modified with Ethylene Glycol Units. Biomaterials 2008, 29(5):551-560.
137. Jiang S.Y., Cao Z.Q. Ultralow-Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications. Adv. Mater. 2010, 22(9):920-932.
138. Ye S.H., Johnson C.A., Woolley J.R., Murata H., Gamble L.J., Ishihara K., Wagner W.R. Simple Surface Modification of a Titanium Alloy with Silanated Zwitterionic Phosphorylcholine or Sulfobetaine Modifiers to Reduce Thrombogenicity. Colloids Surf. B 2010, 79(2):357-364.
139. Zhao J., Shi Q.A., Luan S.F., Song L.J., Yang H.W., Shi H.C., Jin J., Li X.L., Yin J.H., Stagnaro P. Improved Biocompatibility and Antifouling Property of Polypropylene Non-Woven Fabric Membrane by Surface Grafting Zwitterionic Polymer. J. Membrane. Sci. 2011, 369(1-2):5-12.
140. Chang Y., Liao S.C., Higuchi A., Ruaan R.C., Chu C.W., Chen W.Y.A. Highly Stable Nonbiofouling Surface with Well-Packed Grafted Zwitterionic Polysulfobetaine for Plasma Protein Repulsion. Langmuir 2008, 24(10):5453-5458.
141. Kuang J.H., Messersmith P.B. Universal Surface-Initiated Polymerization of Antifouling Zwitterionic Brushes Using a Mussel-Mimetic Peptide Initiator. Langmuir 2012, 28(18):7258-7266.
142. Hower J.C., Bernards M.T., Chen S., Tsao H.K., Sheng Y.J., Jiang S. Hydration of "Nonfouling" Functional Groups. J. Phys. Chem. B 2009, 113(1):197-201.
143. Kane R.S., Deschatelets P., Whitesides G.M. Kosmotropes Form the Basis of Protein-Resistant Surfaces. Langmuir 2003, 19(6):2388-2391.
144. Zhang Z., Zhang M., Chen S.F., Horbetta T.A., Ratner B.D., Jiang S.Y. Blood Compatibility of Surfaces with Superlow Protein Adsorption. Biomaterials 2008, 29(32):4285-4291.
145. Colak S., Tew G.N. Dual-Functional ROMP-Based Betaines: Effect of Hydrophilicity and Backbone Structure on Nonfouling Properties. Langmuir 2012, 28(1):666-675.
146. Colak S., Tew G.N. Amphiphilic Polybetaines: The Effect of Side-Chain Hydrophobicity on Protein Adsorption. Biomacromolecules 2012, 13(5):1233-1239.
147. Chang Y., Shu S.H., Shih Y.J., Chu C.W., Ruaan R.C., Chen W.Y. Hemocompatible Mixed-Charge Copolymer Brushes of Pseudozwitterionic Surfaces Resistant to Nonspecific Plasma Protein Fouling. Langmuir 2010, 26(5):3522-3530.
148. Chen S.F., Jiang S.Y. A New Avenue To Nonfouling Materials. Adv. Mater. 2008, 20(2). 335-338.
149. Nakanishi K., Sakiyama T., Imamura K. On the Adsorption of Proteins on Solid Surfaces, a Common but Very Complicated Phenomenon. J. Biosci. Bioeng. 2001, 91(3):233-244.
150. Park K., Mosher D.F., Cooper S.L. Acute Surface-Induced Thrombosis in the Canine Ex Vivo Model - Importance of Protein-Composition of the Initial Monolayer and Platelet Activation. J. Biomed. Mater. Res. 1986, 20(5):589-612.
151. Sweryda-Krawiec B., Devaraj H., Jacob G., Hickman J.J. A New Interpretation of Serum Albumin Surface Passivation. Langmuir 2004, 20(6):2054-2056.
152. Marois Y., Chakfe N., Guidoin R., Duhamel R.C., Roy R., Marois M., King M.W., Douville Y. An Albumin-Coated Polyester Arterial Graft: In Vivo Assessment of Biocompatibility and Healing Characteristics. Biomaterials 1996, 17(1):3-14.
153. Tanzi M.C. Bioactive Technologies for Hemocompatibility. Expert Rev. Med. Devices 2005, 2(4):473-492.
154. Michiels C. Endothelial Cell Functions. J. Cell. Physiol. 2003, 196(3):430-443.
155. van Hinsbergh V.W.M. The Endothelium: Vascular Control of Haemostasis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 95(2):198-201.
156. Tesfamariam B. Platelet Function in Intravascular Device Implant-Induced Intimal Injury. Cardiovasc. Revasc. Med. 2008, 9(2):78-87.
157. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., Stern D.M. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders. Blood 1998, 91(10):3527-3561.
158. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of Cell Surface Heparan Sulfate Proteoglycans. Annu. Rev. Biochem. 1999, 68:729-777.
159. Whitelock J.M., Iozzo R.V. Heparan Sulfate: A Complex Polymer Charged with Biological Activity. Chem. Rev. 2005, 105(7):2745-2764.
160. Opal S.M., Kessler C.M., Roemisch J., Knaub S. Antithrombin, Heparin, and Heparan Sulfate. Crit. Care Med. 2002, 30(5):S325-S331.
161. Griffith M.J. Kinetics of the Heparin-Enhanced Antithrombin-III Thrombin Reaction - Evidence for a Template Model for the Mechanism of Action of Heparin. J. Biol. Chem. 1982, 257(13):7360-7365.
162. Dittman W.A., Majerus P.W. Structure and Function of Thrombomodulin - A Natural Anticoagulant. Blood 1990, 75(2):329-336.
163. StearnsKurosawa D.J., Kurosawa S., Mollica J.S., Ferrell G.L., Esmon C.T. The Endothelial Cell Protein C Receptor Augments Protein C Activation by the Thrombin-Thrombomodulin Complex. Proc. Natl. Acad. Sci. U. S. A 1996, 93(19):10212-10216.
164. Broze G.J. Tissue Factor Pathway Inhibitor. Thromb. Haemostasis 1995, 74(1):90-93.
165. Hackeng T.M., Maurissen L.F.A., Castoldi E., Rosing J. Regulation of TFPI Function by Protein S. J. Thromb. Haemostasis 2009, 7:165-168.
166. Vallance P., Chan N. Endothelial Function and Nitric Oxide: Clinical Relevance. Heart 2001, 85(3):342-350.
167. Moncada S., Palmer R.M.J., Higgs E.A. Nitric-Oxide - Physiology, Pathophysiology, and Pharmacology. Pharmacol. Rev. 1991, 43(2):109-142.
168. Vane J.R., Botting R.M. Pharmacodynamic Profile of Prostacyclin. Am. J. Cardiol. 1995, 75(3):3A-10A.
169. Shaul P.W. Regulation of Endothelial Nitric Oxide Synthase: Location, Location, Location. Annu. Rev. Physiol. 2002, 64:749-774.
170. Cannon R.O. Role of Nitric Oxide in Cardiovascular Disease: Focus on the Endothelium. Clin. Chem. 1998, 44(8):1809-1819.
171. Knudsen H.L., Frangos J.A. Role of Cytoskeleton in Shear Stress-Induced Endothelial Nitric Oxide Production. Am. J. Physiol. Heart Circ. Physiol. 1997, 273(1):H347-H355.
172. Coade S.B., Pearson J.D. Metabolism of Adenine-Nucleotides in Human-Blood. Circ. Res. 1989, 65(3):531-537.
173. Pepper M.S., Sappino A.P., Stocklin R., Montesano R., Orci L., Vassalli J.D. Upregulation of Urokinase Receptor Expression on Migrating Endothelial Cells. J. Cell Biol. 1993, 122(3):673-684.
174. Levin E.G., Santell L., Osborn K.G. The Expression of Endothelial Tissue Plasminogen Activator In Vivo: A Function Defined by Vessel Size and Anatomic Location. J. Cell Sci. 1997, 110:139-148.
175. Woodhouse K.A., Weitz J.I., Brash J.L. Lysis of Surface-Localized Fibrin Clots by Adsorbed Plasminogen in the Presence of Tissue Plasminogen Activator. Biomaterials 1996, 17(1):75-77.
176. Stein C.M., Brown N., Vaughan D.E., Lang C.C., Wood A.J.J. Regulation of Local Tissue-Type Plasminogen Activator Release by Endothelium-Dependent and Endothelium-Independent Agonists in Human Vasculature. J. Am. Coll. Cardiol. 1998, 32(1):117-122.
177. Mulloy B., Forster M.J. Conformation and Dynamics of Heparin and Heparan Sulfate. Glycobiology 2000, 10(11):1147-1156.
178. Sasisekharan R., Venkataraman G. Heparin and Heparan Sulfate: Biosynthesis, Structure and Function. Curr. Opin. Chem. Biol. 2000, 4(6):626-631.
179. Gott V.L., Whiffen J.D., Dutton R.C. Heparin Bonding on Colloidal Graphite Surfaces. Science 1963, 142(3597):1297.
180. Bosiers M., Deloose K., Verbist J., Schroe H., Lauwers G., Lansink W., Peeters P. Heparin-Bonded Expanded Polytetrafluoroethylene Vascular Graft for Femoropopliteal and Femorocrural Bypass Grafting: 1-Year Results. J. Vasc. Surg. 2006, 43(2):313-318.
181. Haude M., Konorza T.F.M., Kalnins U., Erglis A., Saunamaki K., Glogar H.D., Grube E., Gil R., Serra A., Richardt H.G., Sick P., Erbel R., Invest C.T. Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients. Circulation 2003, 107(9):1265-1270.
182. Jansen P., van Oeveren W., Capel A., Carpentier A. In Vitro Haemocompatibility of a Novel Bioprosthetic Total Artificial Heart. Eur. J. Cardiothorac. Surg. 2012, 41(6):e166-e172.
183. Tagarakis G.I., Tsilimingas N.B. Heparin-Coated Extracorporeal Circulation Systems in Heart Surgery. Recent Pat. Cardiovasc. Drug Discov. 2009, 4(3):177-179.
184. Chanard J., Lavaud S., Maheut H., Kazes I., Vitry F., Rieu P. The Clinical Evaluation of Low-Dose Heparin in Haemodialysis: A Prospective Study Using the Heparin-Coated AN69 ST Membrane. Nephrol. Dial. Transplant. 2008, 23(6):2003-2009.
185. Zhu A.P., Zhang M., Wu J., Shen J. Covalent Immobilization of Chitosan/Heparin Complex with a Photosensitive Hetero-Bifunctional Crosslinking Reagent on PLA Surface. Biomaterials 2002, 23(23):4657-4665.
186. Walluscheck K.P., Bierkandt S., Brandt M., Cremer J. Infrainguinal ePTFE Vascular Graft with Bioactive Surface Heparin Bonding - First Clinical Results. J. Cardiovasc. Surg. 2005, 46(4):425-430.
187. Yu S., Yu Z.T., Wang G., Dargusch M.S., Zhang M.H. Evaluation of Haemocompatibility of TLM Titanium Alloy with Surface Heparinization. Rare Met. Mater. Eng. 2009, 38(3):384-388.
188. Liu M., Yue X.L., Dai Z.F., Xing L., Ma F., Ren N.Q. Stabilized Hemocompatible Coating of Nitinol Devices Based on Photo-Cross-Linked Alginate/Heparin Multilayer. Langmuir 2007, 23(18):9378-9385.
189. Yang Z.L., Wang J., Luo R.F., Maitz M.F., Jing F.J., Sun H., Huang N. The Covalent Immobilization of Heparin to Pulsed-Plasma Polymeric Allylamine Films on 316L Stainless Steel and the Resulting Effects on Hemocompatibility. Biomaterials 2010, 31(8):2072-2083.
190. Tan Q.G., Ji J., Barbosa M.A., Fonseca C., Shen J.C. Constructing Thromboresistant Surface on Biomedical Stainless Steel via Layer-by-Layer Deposition Anticoagulant. Biomaterials 2003, 24(25):4699-4705.
191. Wang A., Cao T., Tang H., Liang X., Salley S.O., Ng K.Y. In Vitro Haemocompatibility and Stability of Two Types of Heparin-Immobilized Silicon Surfaces. Colloids Surf. B 2005, 43(3-4):245-255.
192. Andersson J., Sanchez J., Ekdahl K.N., Elgue G., Nilsson B., Larsson R. Optimal Heparin Surface Concentration and Antithrombin Binding Capacity as Evaluated with Human Non-Anticoagulated Blood In Vitro. J. Biomed. Mater. Res. A 2003, 67A(2):458-466.
193. Murugesan S., Xie J., Linhardt R.J. Immobilization of Heparin: Approaches and Applications. Curr. Top. Med. Chem. 2008, 8(2):80-100.
194. Hardhammar P.A., vanBeusekom H.M.M., Emanuelsson H.U., Hofma S.H., Albertsson P.A., Verdouw P.D., Boersma E., Serruys P.W., VanderGiessen W.J. Reduction in Thrombotic Events with Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries. Circulation 1996, 93(3):423-430.
195. Serruys P.W., Emanuelsson H., vanderGiessen W., Lunn A.C., Kiemeney F., Macaya C., Rutsch W., Heyndrickx G., Suryapranata H., Legrand V., Goy J.J., Materne P., Bonnier H., Morice M.C., Fajadet J., Belardi J., Colombo A., Garcia E., Ruygrok P., deJaegere P., Morel M.A. Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries - Early Outcome of the Benestent-II Pilot Study. Circulation 1996, 93(3):412-422.
196. Li G.C., Zhang F.M., Liao Y.Z., Yang P., Huang N. Coimmobilization of Heparin/Fibronectin Mixture on Titanium Surfaces and Their Blood Compatibility. Colloids Surf. B 2010, 81(1):255-262.
197. Li G.C., Yang P., Qin W., Maitz M.F., Zhou S., Huang N. The Effect of Coimmobilizing Heparin and Fibronectin on Titanium on Hemocompatibility and Endothelialization. Biomaterials 2011, 32(21):4691-4703.
198. Chen J.L., Chen C., Chen Z.Y., Chen J.Y., Li Q.L., Huang N. Collagen/Heparin Coating on Titanium Surface Improves the Biocompatibility of Titanium Applied as a Blood-Contacting Biomaterial. J. Biomed. Mater. Res. A 2010, 95A(2):341-349.
199. Guo Q.K., Lu Z.Q., Wang J.Y., Li T. In Vivo Evaluation of a Novel Dexamethasone-Heparin-Double-Coated Stent for Inhibition of Artery Restenosis and Thrombosis. J. Mater. Sci. Mater. Med. 2011, 22(6):1615-1623.
200. Holmer E., Kurachi K., Soderstrom G. The Molecular-Weight Dependence of the Rate-Enhancing Effect of Heparin on the Inhibition of Thrombin, Factor-Xa, Factor-IXa, Factor-XIa, Factor-XIIa and Kallikrein by Anti-Thrombin. Biochem. J. 1981, 193(2):395-400.
201. Chan A., Berry L., OBrodovich H., Klement P., Mitchell L., Baranowski B., Monagle P., Andrew M. Covalent Antithrombin-Heparin Complexes with High Anticoagulant Activity - Intravenous, Subcutaneous, and Intratracheal Administration. J. Biol. Chem. 1997, 272(35):22111-22117.
202. Berry L., Stafford A., Fredenburgh J., O'Brodovich H., Mitchell L., Weitz J., Andrew M., Chan A.K.C. Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex. J. Biol. Chem. 1998, 273(52):34730-34736.
203. Sask K.N., McClung W.G., Berry L.R., Chan A.K.C., Brash J.L. Immobilization of an Antithrombin-Heparin Complex on Gold: Anticoagulant Properties and Platelet Interactions. Acta Biomater. 2011, 7(5):2029-2034.
204. Weitz J.I., Crowther M. Direct Thrombin Inhibitors. Thromb. Res. 2002, 106(3):V275-V284.
205. Davenport A. Review Article: Low-Molecular-Weight Heparin as an Alternative Anticoagulant to Unfractionated Heparin for Routine Outpatient Haemodialysis Treatments. Nephrology 2009, 14(5):455-461.
206. Gandhi N.S., Mancera R.L. Heparin/Heparan Sulphate-Based Drugs. Drug Discov. Today 2010, 15(23-24):1058-1069.
207. Mourao P.A.S., Pereira M.S. Searching for Alternatives to Heparin - Sulfated Fucans from Marine Invertebrates. Trends Cardiovasc. Med. 1999, 9(8):225-232.
208. Kishida A., Akatsuka Y., Yanagi M., Aikou T., Maruyama I., Akashi M. In Vivo and Ex Vivo Evaluation of the Antithrombogenicity of Human Thrombomodulin Immobilized Biomaterials. ASAIO J. 1995, 41(3):M369-M374.
209. Sperling C., Salchert K., Streller U., Werner C. Covalently Immobilized Thrombomodulin Inhibits Coagulation and Complement Activation of Artificial Surfaces In Vitro. Biomaterials 2004, 25(21):5101-5113.
210. Tseng P.Y., Rele S.S., Sun X.L., Chaikof E.L. Membrane-Mimetic Films Containing Thrombomodulin and Heparin Inhibit Tissue Factor-Induced Thrombin Generation in a Flow Model. Biomaterials 2006, 27(12):2637-2650.
211. Bhatt D.L., Topol E.J. Scientific and Therapeutic Advances in Antiplatelet Therapy. Nat. Rev. Drug Discov. 2003, 2(1):15-28.
212. de Mel A., Murad F., Seifalian A.M. Nitric Oxide: A Guardian for Vascular Grafts?. Chem. Rev. 2011, 111(9):5742-5767.
213. Reichenbach G., Momi S., Gresele P. Nitric Oxide and its Antithrombotic Action in the Cardiovascular System. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5(1):65-74.
214. Cheung P.Y., Salas E., Etches P.C., Phillipos E., Schulz R., Radomski M.W. Inhaled Nitric Oxide and Inhibition of Platelet Aggregation in Critically Ill Neonates. Lancet 1998, 351(9110):1181-1182.
215. Radomski M.W., Palmer R.M.J., Moncada S. The Role of Nitric-Oxide and CGMP in Platelet-Adhesion to Vascular Endothelium. Biochem. Biophys. Res. Commun. 1987, 148(3):1482-1489.
216. Annich G.M., Meinhardt J.P., Mowery K.A., Ashton B.A., Merz S.I., Hirschl R.B., Meyerhoff M.E., Bartlett R.H. Reduced Platelet Activation and Thrombosis in Extracorporeal Circuits Coated with Nitric Oxide Release Polymers. Crit. Care Med. 2000, 28(4):915-920.
217. Schoenfisch M.H., Mowery K.A., Rader M.V., Baliga N., Wahr J.A., Meyerhoff M.E. Improving the Thromboresistivity of Chemical Sensors via Nitric Oxide Release: Fabrication and In Vivo Evaluation of NO-Releasing Oxygen-Sensing Catheters. Anal. Chem. 2000, 72(6):1119-1126.
218. Parzuchowski P.G., Frost M.C., Meyerhoff M.E. Synthesis and Characterization of Polymethacrylate-Based Nitric Oxide Donors. J. Am. Chem. Soc. 2002, 124(41):12182-12191.
219. Wang P.G., Xian M., Tang X.P., Wu X.J., Wen Z., Cai T.W., Janczuk A.J. Nitric Oxide Donors: Chemical Activities and Biological Applications. Chem. Rev. 2002, 102(4):1091-1134.
220. Ignarro L.J., Napoli C., Loscalzo J. Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide - An Overview. Circ. Res. 2002, 90(1):21-28.
221. Fitzhugh A.L., Keefer L.K. Diazeniumdiolates: Pro- and Antioxidant Applications of the "NONOates". Free Radicals Biol. Med. 2000, 28(10):1463-1469.
222. Smith D.J., Chakravarthy D., Pulfer S., Simmons M.L., Hrabie J.A., Citro M.L., Saavedra J.E., Davies K.M., Hutsell T.C., Mooradian D.L., Hanson S.R., Keefer L.K. Nitric Oxide-Releasing Polymers Containing the N(O)NO.(-) Group. J. Med. Chem. 1996, 39(5):1148-1156.
223. Major T.C., Brant D.O., Reynolds M.M., Bartlett R.H., Meyerhoff M.E., Handa H., Annich G.M. The Attenuation of Platelet and Monocyte Activation in a Rabbit Model of Extracorporeal Circulation by a Nitric Oxide Releasing Polymer. Biomaterials 2010, 31(10):2736-2745.
224. Jun H.W., Taite L.J., West J.L. Nitric Oxide-Producing Polyurethanes. Biomacromolecules 2005, 6(2):838-844.
225. Taite L.J., Yang P., Jun H.W., West J.L. Nitric Oxide-Releasing Polyurethane-PEG Copolymer Containing the YIGSR Peptide Promotes Endothelialization with Decreased Platelet Adhesion. J. Biomed. Mater. Res. B 2008, 84B(1):108-116.
226. Zhang H.P., Annich G.M., Miskulin J., Stankiewicz K., Osterholzer K., Merz S.I., Bartlett R.H., Meyerhoff M.E. Nitric Oxide-Releasing Fumed Silica Particles: Synthesis, Characterization, and Biomedical Application. J. Am. Chem. Soc. 2003, 125(17):5015-5024.
227. Al-Sa'doni H., Ferro A. S-Nitrosothiols: A Class of Nitric Oxide-Donor Drugs. Clin. Sci. 2000, 98(5):507-520.
228. Wu K.K., Thiagarajan P. Role of Endothelium in Thrombosis and Hemostasis. Annu. Rev. Med. 1996, 47:315-331.
229. Nerem R.M., Ensley A.E. The Tissue Engineering of Blood Vessels and the Heart. Am. J. Transplant. 2004, 4:36-42.
230. Baguneid M.S., Seifalian A.M., Salacinski H.J., Murray D., Hamilton G., Walker M.G. Tissue Engineering of Blood Vessels. Br. J. Surg. 2006, 93(3):282-290.
231. Weng Y.J., Chen J.Y., Tu Q.F., Li Q.L., Maitz M.F., Huang N. Biomimetic Modification of Metallic Cardiovascular Biomaterials: From Function Mimicking to Endothelialization In Vivo. Interface Focus 2012, 2(3):356-365.
232. de Mel A., Jell G., Stevens M.M., Seifalian A.M. Biofunctionalization of Biomaterials for Accelerated In Situ Endothelialization: A Review. Biomacromolecules 2008, 9(11):2969-2979.
233. McGuigan A.P., Sefton M.V. The Influence of Biomaterials on Endothelial Cell Thrombogenicity. Biomaterials 2007, 28(16):2547-2571.
234. Herring M., Smith J., Dalsing M., Glover J., Compton R., Etchberger K., Zollinger T. Endothelial Seeding of Polytetrafluoroethylene Femoral Popliteal Bypasses - The Failure of Low-Density Seeding to Improve Patency. J. Vasc. Surg. 1994, 20(4):650-655.
235. Kidd K.R., Patula V.B., Williams S.K. Accelerated Endothelialization of Interpositional 1-mm Vascular Grafts. J. Surg. Res. 2003, 113(2):234-242.
236. Massia S.P., Hubbell J.A. Immobilized Amines and Basic-Amino-Acids as Mimetic Heparin-Binding Domains for Cell-Surface Proteoglycan-Mediated Adhesion. J. Biol. Chem. 1992, 267(14):10133-10141.
237. Zhu Y.B., Gao C.Y., Liu Y.X., Shen J.C. Endothelial Cell Functions In Vitro Cultured on Poly(L-Lactic Acid) Membranes Modified with Different Methods. J. Biomed. Mater. Res. A 2004, 69A(3):436-443.
238. Lu A., Sipehia R. Antithrombotic and Fibrinolytic System of Human Endothelial Cells Seeded on PTFE: The Effects of Surface Modification of PTFE by Ammonia Plasma Treatment and ECM Protein Coatings. Biomaterials 2001, 22(11):1439-1446.
239. Jun H.W., West J.L. Endothelialization of Microporous YIGSR/PEG-Modified Polyurethaneurea. Tissue Eng. 2005, 11(7-8):1133-1140.
240. Li J.H., Ding M.M., Fu Q., Tan H., Xie X.Y., Zhong Y.P. A Novel Strategy to Graft RGD Peptide on Biomaterials Surfaces for Endothelialization of Small-Diameter Vascular Grafts and Tissue Engineering Blood Vessel. J. Mater. Sci. Mater. Med. 2008, 19(7):2595-2603.
241. Walluscheck K.P., Steinhoff G., Kelm S., Haverich A. Improved Endothelial Cell Attachment on ePTFE Vascular Grafts Pretreated with Synthetic RGD-Containing Peptides. Eur. J. Vasc. Endovasc. 1996, 12(3):321-330.
242. Chung T.W., Lu Y.F., Wang S.S., Lin Y.S., Chu S.H. Growth of Human Endothelial Cells on Photochemically Grafted Gly-Arg-Gly-Asp (GRGD) Chitosans. Biomaterials 2002, 23(24):4803-4809.
243. Lim S.H., Cho S.W., Park J.C., Jeon O., Lim J.M., Kim S.S., Kim B.S. Tissue-Engineered Blood Vessels with Endothelial Nitric Oxide Synthase Activity. J. Biomed. Mater. Res. B 2008, 85B(2):537-546.
244. Liu J.Y., Swartz D.D., Peng H.F., Gugino S.F., Russell J.A., Andreadis S.T. Functional Tissue-Engineered Blood Vessels from Bone Marrow Progenitor Cells. Cardiovasc. Res. 2007, 75(3):618-628.
245. Hoenig M.R., Campbell G.R., Rolfe B.E., Campbell J.H. Tissue-Engineered Blood Vessels - Alternative to Autologous Grafts?. Arterioscler. Thromb. Vasc. Biol. 2005, 25(6):1128-1134.
246. Krawiec J.T., Vorp D.A. Adult Stem Cell-Based Tissue Engineered Blood Vessels: A Review. Biomaterials 2012, 33(12):3388-3400.
247. Northup S.J. In Vitro Assessment of Tissue Compatibility. An Introduction to Tissue-Biomaterial Interactions 2004, 73-79. (chapter 5.2), John Wiley & Sons, Inc., New York. 2nd ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
248. Williams D.F. On the Nature of Biomaterials. Biomaterials 2009, 30(30):5897-5909.
249. Hubbell J.A., Thomas S.N., Swartz M.A. Materials Engineering for Immunomodulation. Nature 2009, 462(7272):449-460.
250. Gumbiner B.M. Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis. Cell 1996, 84(3):345-357.
251. Lehnert D., Wehrle-Haller B., David C., Weiland U., Ballestrem C., Imhof B.A., Bastmeyer M. Cell Behaviour on Micropatterned Substrata: Limits of Extracellular Matrix Geometry for Spreading and Adhesion. J. Cell Sci. 2004, 117(1):41-52.
252. Flemming R.G., Murphy C.J., Abrams G.A., Goodman S.L., Nealey P.F. Effects of Synthetic Micro- and Nano-Structured Surfaces on Cell Behavior. Biomaterials 1999, 20(6):573-588.
253. Brodbeck W.G., Patel J., Voskerician G., Christenson E., Shive M.S., Nakayama Y., Matsuda T., Ziats N.P., Anderson J.M. Biomaterial Adherent Macrophage Apoptosis is Increased by Hydrophilic and Anionic Substrates In Vivo. Proc. Natl. Acad. Sci. U. S. A 2002, 99(16):10287-10292.
254. Yim E.K., Leong K.W. Significance of Synthetic Nanostructures in Dictating Cellular Response. Nanomedicine 2005, 1(1):10-21.
255. Schulte V.A., Diez M., Moller M., Lensen M.C. Surface Topography Induces Fibroblast Adhesion on Intrinsically Nonadhesive Poly(Ethylene Glycol) Substrates. Biomacromolecules 2009, 10(10):2795-2801.
256. Andersson A.S., Backhed F., von Euler A., Richter-Dahlfors A., Sutherland D., Kasemo B. Nanoscale Features Influence Epithelial Cell Morphology and Cytokine Production. Biomaterials 2003, 24(20):3427-3436.
257. Dalby M.J., Riehle M.O., Johnstone H., Affrossman S., Curtis A.S.G. In Vitro Reaction of Endothelial Cells to Polymer Demixed Nanotopography. Biomaterials 2002, 23(14):2945-2954.
258. Chen S.L., Jones J.A., Xu Y.G., Low H.Y., Anderson J.M., Leong K.W. Characterization of Topographical Effects on Macrophage Behavior in a Foreign Body Response Model. Biomaterials 2010, 31(13):3479-3491.
259. Franchimont D., Kino T., Galon J., Meduri G.U., Chrousos G. Glucocorticoids and Inflammation Revisited: The State of the Art. Neuroimmunomodulation 2002, 10(5):247-260.
260. Bogdan C. Nitric Oxide and the Immune Response. Nat. Immunol. 2001, 2(10):907-916.
261. Hetrick E.M., Prichard H.L., Klitzman B., Schoenfisch M.H. Reduced Foreign Body Response at Nitric Oxide-Releasing Subcutaneous Implants. Biomaterials 2007, 28(31):4571-4580.
262. Gifford R., Batchelor M.M., Lee Y., Gokulrangan G., Meyerhoff M.E., Wilson G.S. Mediation of In Vivo Glucose Sensor Inflammatory Response via Nitric Oxide Release. J. Biomed. Mater. Res. A 2005, 75A(4):755-766.
263. Schwentker A., Vodovotz Y., Weller R., Billiar T.R. Nitric Oxide and Wound Repair: Role of Cytokines?. Nitric Oxide Biol. Chem. 2002, 7(1):1-10.
264. Jimenez J.L., Gonzalez-Nicolas J., Alvarez S., Fresno M., Munoz-Fernandez M.A. Regulation of Human Immunodeficiency Virus Type 1 Replication in Human T Lymphocytes by Nitric Oxide. J. Virol. 2001, 75(10):4655-4663.
265. Darouiche R.O. Current Concepts - Treatment of Infections Associated with Surgical Implants. N. Engl. J. Med. 2004, 350(14):1422-1429.
266. Schutzer S.F., Harris W.H. Deep-Wound Infection after Total Hip-Replacement under Contemporary Aseptic Conditions. J. Bone Joint Surg. Am. 1988, 70A(5):724-727.
267. Vasilev K., Cook J., Griesser H.J. Antibacterial Surfaces for Biomedical Devices. Expert Rev. Med. Devices 2009, 6(5):553-567.
268. Zhao L.Z., Chu P.K., Zhang Y.M., Wu Z.F. Antibacterial Coatings on Titanium Implants. J. Biomed. Mater. Res. B 2009, 91B(1):470-480.
269. Ramritu P., Halton K., Collignon P., Cook D., Fraenkel D., Battistutta D., Whitby M., Graves N. A Systematic Review Comparing the Relative Effectiveness of Antimicrobial-Coated Catheters in Intensive Care Units. Am. J. Infect. Control 2008, 36(2):104-117.
270. Coughlan A., Boyd D., Douglas C.W.I., Towler M.R. Antibacterial Coatings for Medical Devices Based on Glass Polyalkenoate Cement Chemistry. J. Mater. Sci. Mater. Med. 2008, 19(12):3555-3560.
271. Gristina A.G. Biomaterial-Centered Infection - Microbial Adhesion versus Tissue Integration. Science 1987, 237(4822):1588-1595.
272. Gottenbos B., Busscher H.J., van der Mei H.C. Pathogenesis and Prevention of Biomaterial Centered Infections. J. Mater. Sci. Mater. Med. 2002, 13(8):717-722.
273. Boks N.P., Norde W., van der Mei H.C., Busscher H.J. Forces Involved in Bacterial Adhesion to Hydrophilic and Hydrophobic Surfaces. Microbiol. SGM 2008, 154:3122-3133.
274. Donlan R.M. Biofilm Formation: A Clinically Relevant Microbiological Process. Clin. Infect. Dis. 2001, 33(8):1387-1392.
275. Flemming H.C., Wingender J. The Biofilm Matrix. Nat. Rev. Microbiol. 2010, 8(9):623-633.
276. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial Biofilms: From the Natural Environment to Infectious Diseases. Nat. Rev. Microbiol. 2004, 2(2):95-108.
277. Lewis K. Riddle of Biofilm Resistance. Antimicrob. Agents Chemother. 2001, 45(4):999-1007.
278. Hetrick E.M., Schoenfisch M.H. Reducing Implant-Related Infections: Active Release Strategies. Chem. Soc. Rev. 2006, 35(9):780-789.
279. Zilberman M., Elsner J.J. Antibiotic-Eluting Medical Devices for Various Applications. J. Controlled Release 2008, 130(3):202-215.
280. Wu P., Grainger D.W. Drug/Device Combinations for Local Drug Therapies and Infection Prophylaxis. Biomaterials 2006, 27(11):2450-2467.
281. Springer B.D., Lee G.C., Osmon D., Haidukewych G.J., Hanssen A.D., Jacofsky D.J. Systemic Safety of High-Dose Antibiotic-Loaded Cement Spacers after Resection of an Infected Total Knee Arthroplasty. Clin. Orthop. Relat. Res. 2004, 427:47-51.
282. Stigter M., Bezemer J., de Groot K., Layrolle P. Incorporation of Different Antibiotics into Carbonated Hydroxyapatite Coatings on Titanium Implants, Release and Antibiotic Efficacy. J. Controlled Release 2004, 99(1):127-137.
283. Price J.S., Tencer A.F., Arm D.M., Bohach G.A. Controlled Release of Antibiotics from Coated Orthopedic Implants. J. Biomed. Mater. Res. 1996, 30(3):281-286.
284. Neut D., van de Belt H., Stokroos I., van Horn J.R., van der Mei H.C., Busscher H.J. Biomaterial-Associated Infection of Gentamicin-Loaded PMMA Beads in Orthopaedic Revision Surgery. J. Antimicrob. Chemother. 2001, 47(6):885-891.
285. Rossi S., Azghani A.O., Omri A. Antimicrobial Efficacy of a New Antibiotic-Loaded Poly(Hydroxybutyric-Co-Hydroxyvaleric Acid) Controlled Release System. J. Antimicrob. Chemother. 2004, 54(6):1013-1018.
286. Aviv M., Berdicevsky I., Zilberman M. Gentamicin-Loaded Bioresorbable Films for Prevention of Bacterial Infections Associated with Orthopedic Implants. J. Biomed. Mater. Res. A 2007, 83A(1):10-19.
287. Scott C.P., Higham P.A. Antibiotic Bone Cement for the Treatment of Pseudomonas aeruginosa in Joint Arthroplasty: Comparison of Tobramycin and Gentamicin-Loaded Cements. J. Biomed. Mater. Res. B 2003, 64(2):94-98.
288. Scott C.P., Higham P.A., Dumbleton J.H. Effectiveness of Bone Cement Containing Tobramycin - An In Vitro Susceptibility Study of 99 Organisms Found in Infected Joint Arthroplasty. J. Bone Joint Surg. Br. 1999, 81B(3):440-443.
289. Nelson C.L., Griffin F.M., Harrison B.H., Cooper R.E. In Vitro Elution Characteristics of Commercially and Noncommercially Prepared Antibiotic PMMA Beads. Clin. Orthop. Relat. Res. 1992, 284:303-309.
290. Sterling G.J., Crawford S., Potter J.H., Koerbin G., Crawford R. The Pharmacokinetics of Simplex-Tobramycin Bone Cement. J. Bone Joint Surg. Br. 2003, 85B(5):646-649.
291. Walenkamp G.H.I.M. How I Do It - Chronic Osteomyelitis. Acta Orthop. Scand. 1997, 68(5):497-506.
292. Heck D., Rosenberg A., Schinkascani M., Garbus S., Kiewitt T. Use of Antibiotic-Impregnated Cement during Hip and Knee Arthroplasty in the United-States. J. Arthroplasty 1995, 10(4):470-475.
293. Kanellakopoulou K., Giamarellos-Bourboulis E.J. Carrier Systems for the Local Delivery of Antibiotics in Bone Infections. Drugs 2000, 59(6):1223-1232.
294. Hoff S.F., Fitzgerald R.H., Kelly P.J. The Depot Administration of Penicillin-G and Gentamicin in Acrylic Bone-Cement. J. Bone Joint Surg. Am. 1981, 63(5):798-804.
295. Stigter M., de Groot K., Layrolle P. Incorporation of Tobramycin into Biomimetic Hydroxyapatite Coating on Titanium. Biomaterials 2002, 23(20):4143-4153.
296. Radin S., Campbell J.T., Ducheyne P., Cuckler J.M. Calcium Phosphate Ceramic Coatings as Carriers of Vancomycin. Biomaterials 1997, 18(11):777-782.
297. Subramani K., Jung R.E., Molenberg A., Hammerle C.H.F. Biofilm on Dental Implants: A Review of the Literature. Int. J. Oral Maxillofac. Implants 2009, 24(4):616-626.
298. Aumsuwan N., Danyus R.C., Heinhorst S., Urban M.W. Attachment of Ampicillin to Expanded Poly(Tetrafluoroethylene): Surface Reactions Leading to Inhibition of Microbial Growth. Biomacromolecules 2008, 9(7):1712-1718.
299. Aumsuwan N., Heinhorst S., Urban M.W. Antibacterial Surfaces on Expanded Polytetrafluoroethylene Penicillin Attachment. Biomacromolecules 2007, 8(2):713-718.
300. Fabiola Costa, Isabel F.Carvalho, Ronald C.Montelaro, Gomes P., Cristina M., Martins L. Covalent Immobilization of Antimicrobial Peptides (AMPs) onto Biomaterial surfaces. Acta Biomater 2011, 7:1431.
301. Russell A.D., Hugo W.B. Antimicrobial Activity and Action of Silver. Prog. Med. Chem. 1994, 31:351-370.
302. Silver S. Bacterial Silver Resistance: Molecular Biology and Uses and Misuses of Silver Compounds. FEMS Microbiol. Rev. 2003, 27(2-3):341-353.
303. Rai M., Yadav A., Gade A. Silver Nanoparticles as a New Generation of Antimicrobials. Biotechnol. Adv. 2009, 27(1):76-83.
304. Rupp M.E., Fitzgerald T., Marion N., Helget V., Puumala S., Anderson J.R., Fey P.D. Effect of Silver-Coated Urinary Catheters: Efficacy, Cost-Effectiveness, and Antimicrobial Resistance. Am. J. Infect. Control 2004, 32(8):445-450.
305. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H.Z., Tam P.K.H., Chiu J.F., Che C.M. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles. J. Proteome Res. 2006, 5(4):916-924.
306. Kong H., Jang J. Antibacterial Properties of Novel Poly(Methyl Methacrylate) Nanofiber Containing Silver Nanoparticles. Langmuir 2008, 24(5):2051-2056.
307. Sambhy V., Peterson B.R., Sen A. Multifunctional Silane Polymers for Persistent Surface Derivatization and Their Antimicrobial Properties. Langmuir 2008, 24(14):7549-7558.
308. Mallick K., Witcomb M.J., Scurrell M.S. Self-Assembly of Silver Nanoparticles: Formation of a Thin Silver Film in a Polymer Matrix. Mater. Sci. Eng. C 2006, 26(1):87-91.
309. Lu J., Moon K.S., Wong C.P. Silver/Polymer Nanocomposite as a High-K Polymer Matrix for Dielectric Composites with Improved Dielectric Performance. J. Mater. Chem. 2008, 18(40):4821-4826.
310. Gray J.E., Norton P.R., Griffiths K. Mechanism of Adhesion of Electroless-Deposited Silver on Poly(Ether Urethane). Thin Solid Films 2005, 484(1-2):196-207.
311. Galya T., Sedlarik V., Kuritka I., Novotny R., Sedlarikova J., Saha P. Antibacterial Poly(Vinyl Alcohol) Film Containing Silver Nanoparticles: Preparation and Characterization. J. Appl. Polym. Sci. 2008, 110(5):3178-3185.
312. Zaporojtchenko V., Podschun R., Schurmann U., Kulkarni A., Faupel F. Physico-Chemical and Antimicrobial Properties of Co-Sputtered Ag-Au/PTFE Nanocomposite Coatings. Nanotechnology 2006, 17(19):4904-4908.
313. Voccia S., Ignatova M., Jerome R., Jerome C. Design of Antibacterial Surfaces by a Combination of Electrochemistry and Controlled Radical Polymerization. Langmuir 2006, 22(20):8607-8613.
314. Wan Y.Z., Raman S., He F., Huang Y. Surface Modification of Medical Metals by Ion Implantation of Silver and Copper. Vacuum 2007, 81(9):1114-1118.
315. Cao H.L., Liu X.Y., Meng F.H., Chu P.K. Biological Actions of Silver Nanoparticles Embedded in Titanium Controlled by Micro-Galvanic Effects. Biomaterials 2011, 32(3):693-705.
316. Ewald A., Gluckermann S.K., Thull R., Gbureck U. Antimicrobial Titanium/Silver PVD Coatings on Titanium. Biomed. Eng. Online 2006, 5.
317. Chen W., Liu Y., Courtney H.S., Bettenga M., Agrawal C.M., Bumgardner J.D., Ong J.L. In Vitro Anti-Bacterial and Biological Properties of Magnetron Co-Sputtered Silver-Containing Hydroxyapatite Coating. Biomaterials 2006, 27(32):5512-5517.
318. Tiller J.C., Liao C.J., Lewis K., Klibanov A.M. Designing Surfaces that Kill Bacteria on Contact. Proc. Natl. Acad. Sci. U. S. A 2001, 98(11):5981-5985.
319. Harris L.G., Richards R.G. Staphylococci and Implant Surfaces: A Review. Injury 2006, 37:3-14.
320. Kugler R., Bouloussa O., Rondelez F. Evidence of a Charge-Density Threshold for Optimum Efficiency of Biocidal Cationic Surfaces. Microbiol. SGM 2005, 151:1341-1348.
321. Murata H., Koepsel R.R., Matyjaszewski K., Russell A.J. Permanent, Non-Leaching Antibacterial Surfaces - 2: How High Density Cationic Surfaces Kill Bacterial Cells. Biomaterials 2007, 28(32):4870-4879.
322. Huang J.Y., Koepsel R.R., Murata H., Wu W., Lee S.B., Kowalewski T., Russell A.J., Matyjaszewski K. Nonleaching Antibacterial Glass Surfaces via "Grafting Onto": The Effect of the Number of Quaternary Ammonium Groups on Biocidal Activity. Langmuir 2008, 24(13):6785-6795.
323. Bouloussa O., Rondelez F., Semetey V. A New, Simple Approach to Confer Permanent Antimicrobial Properties to Hydroxylated Surfaces by Surface Functionalization. Chem. Commun. 2008, 8:951-953.
324. Brizzolara R.A., Stamper D.M. The Effect of Covalent Surface Immobilization on the Bactericidal Efficacy of a Quaternary Ammonium Compound. Surf. Interface Anal. 2007, 39(7):559-566.
325. Saif M.J., Anwar J., Munawar M.A. A Novel Application of Quaternary Ammonium Compounds as Antibacterial Hybrid Coating on Glass Surfaces. Langmuir 2009, 25(1):377-379.
326. Thebault P., de Givenchy E.T., Levy R., Vandenberghe Y., Guittard F., Geribaldi S. Preparation and Antimicrobial Behaviour of Quaternary Ammonium Thiol Derivatives Able to be Grafted on Metal Surfaces. Eur. J. Med. Chem. 2009, 44(2):717-724.
327. Marini M., Bondi M., Iseppi R., Toselli M., Pilati F. Preparation and Antibacterial Activity of Hybrid Materials Containing Quaternary Ammonium Salts via Sol-Gel Process. Eur. Polym. J. 2007, 43(8):3621-3628.
328. McCubbin P.J., Forbes E., Gow M.M., Gorham S.D. Covalent Attachment of Quaternary Ammonium Compounds to a Polyethylene Surface via a Hydrolyzable Ester Linkage: Basis for a Controlled-Release System of Antiseptics from an Inert Surface. J. Appl. Polym. Sci. 2006, 100(1):538-545.
329. Huang J.Y., Murata H., Koepsel R.R., Russell A.J., Matyjaszewski K. Antibacterial Polypropylene via Surface-Initiated Atom Transfer Radical Polymerization. Biomacromolecules 2007, 8(5):1396-1399.
330. Jampala S.N., Sarmadi M., Somers E.B., Wong A.C.L., Denes F.S. Plasma-Enhanced Synthesis of Bactericidal Quaternary Ammonium Thin Layers on Stainless Steel and Cellulose Surfaces. Langmuir 2008, 24(16):8583-8591.
331. Li Z., Lee D., Sheng X.X., Cohen R.E., Rubner M.F. Two-Level Antibacterial Coating with Both Release-Killing and Contact-Killing Capabilities. Langmuir 2006, 22(24):9820-9823.
332. Mannick.Joan B. Immunoregulatory and Antimicrobial Effects of Nitrogen Oxides. Proc. Am. Thorac. Soc. 2006, 3(2):161-165.
333. Fang F. Mechanisms of Nitric Oxide-Related Antimicrobial Activity. J. Clin. Invest. 1997, 99(12):2818-2825.
334. Nablo B.J., Rothrock A.R., Schoenfisch M.H. Nitric Oxide-Releasing Sol-Gels as Antibacterial Coatings for Orthopedic Implants. Biomaterials 2005, 26(8):917-924.
335. Charville G.W., Hetrick E.M., Geer C.B., Schoenfisch M.H. Reduced Bacterial Adhesion to Fibrinogen-Coated Substrates via Nitric Oxide Release. Biomaterials 2008, 29(30):4039-4044.
336. Frost M.C., Reynolds M.M., Meyerhoff M.E. Polymers Incorporating Nitric Oxide Releasing/Generating Substances for Improved Biocompatibility of Blood-Contacting Medical Devices. Biomaterials 2005, 26(14):1685-1693.
337. Watanabe T., Nakajima A., Wang R., Minabe M., Koizumi S., Fujishima A., Hashimoto K. Photocatalytic Activity and Photoinduced Hydrophilicity of Titanium Dioxide Coated Glass. Thin Solid Films 1999, 351(1-2):260-263.
338. Gallardo-Moreno A.M., Pacha-Olivenza M.A., Saldana L., Perez-Giraldo C., Bruque J.M., Vilaboa N., Gonzalez-Martin M.L. In Vitro Biocompatibility and Bacterial Adhesion of Physico-Chemically Modified Ti6Al4V Surface by Means of UV Irradiation. Acta Biomater. 2009, 5(1):181-192.
339. Aita H., Hori N., Takeuchi M., Suzuki T., Yamada M., Anpo M., Ogawa T. The Effect of Ultraviolet Functionalization of Titanium on Integration with Bone. Biomaterials 2009, 30(6):1015-1025.
340. Oehr C. Plasma Surface Modification of Polymers for Biomedical Use. Nucl. Instrum. Methods Phys. Res. B 2003, 208:40-47.
341. Triandafillu K., Balazs D.J., Aronsson B.O., Descouts P., Quoc P.T., van Delden C., Mathieu H.J., Harms H. Adhesion of Pseudomonas Aeruginosa Strains to Untreated and Oxygen-Plasma Treated Poly(Vinyl Chloride) (PVC) from Endotracheal Intubation Devices. Biomaterials 2003, 24(8):1507-1518.
342. Balazs D.J., Triandafillu K., Chevolot Y., Aronsson B.O., Harms H., Descouts P., Mathieu H.J. Surface Modification of PVC Endotracheal Tubes by Oxygen Glow Discharge to Reduce Bacterial Adhesion. Surf. Interface Anal. 2003, 35(3):301-309.
343. Balazs D.J., Triandafillu K., Wood P., Chevolot Y., van Delden C., Harms H., Hollenstein C., Mathieu H.J. Inhibition of Bacterial Adhesion on PVC Endotracheal Tubes by RF-Oxygen Glow Discharge, Sodium Hydroxide and Silver Nitrate Treatments. Biomaterials 2004, 25(11):2139-2151.
344. Asadinezhad A., Novak I., Lehocky M., Sedlarik V., Vesel A., Junkar I., Saha P., Chodak I. A Physicochemical Approach to Render Antibacterial Surfaces on Plasma-Treated Medical-Grade PVC: Irgasan Coating. Plasma Process. Polym. 2010, 7(6):504-514.
345. Asadinezhad A., Novak I., Lehocky M., Sedlarik V., Vesel A., Junkar I., Saha P., Chodak I. An In Vitro Bacterial Adhesion Assessment of Surface-Modified Medical-Grade PVC. Colloids Surf. B 2010, 77(2):246-256.
346. x) Coatings with Different Resistivities: A Novel Approach for the Development of Biomaterials. Biomaterials 2002, 23(14):2835-2840.
347. Park K.D., Kim Y.S., Han D.K., Kim Y.H., Lee E.H.B., Suh H., Choi K.S. Bacterial Adhesion on PEG Modified Polyurethane Surfaces. Biomaterials 1998, 19(7-9):851-859.
348. Terada A., Yuasa A., Tsuneda S., Hirata A., Katakai A., Tamada M. Elucidation of Dominant Effect on Initial Bacterial Adhesion onto Polymer Surfaces Prepared by Radiation-Induced Graft Polymerization. Colloids Surf. B 2005, 43(2):99-107.
349. Fernandez I.C.S., van der Mei H.C., Metzger S., Grainger D.W., Engelsman A.F., Nejadnik M.R., Busscher H.J. In Vitro and In Vivo Comparisons of Staphylococcal Biofilm Formation on a Cross-Linked Poly(Ethylene Glycol)-Based Polymer Coating. Acta Biomater. 2010, 6(3):1119-1124.
350. Holmes P.F., Currie E.P.K., Thies J.C., van der Mei H.C., Busscher H.J., Norde W. Surface-Modified Nanoparticles as a New, Versatile, and Mechanically Robust Nonadhesive Coating: Suppression of Protein Adsorption and Bacterial Adhesion. J. Biomed. Mater. Res. A 2009, 91A(3):824-833.
351. Nejadnik M.R., van der Mei H.C., Norde W., Busscher H.J. Bacterial Adhesion and Growth on a Polymer Brush-Coating. Biomaterials 2008, 29(30):4117-4121.
352. Fernandez I.C.S., van der Mei H.C., Lochhead M.J., Grainger D.W., Busscher H.J. The Inhibition of the Adhesion of Clinically Isolated Bacterial Strains on Multi-Component Cross-Linked Poly(Ethylene Glycol)-Based Polymer Coatings. Biomaterials 2007, 28(28):4105-4112.
353. Maddikeri R.R., Tosatti S., Schuler M., Chessari S., Textor M., Richards R.G., Harris L.G. Reduced Medical Infection Related Bacterial Strains Adhesion on Bioactive RGD Modified Titanium Surfaces: A First Step toward Cell Selective Surfaces. J. Biomed. Mater. Res. A 2008, 84A(2):425-435.
354. Cheng G., Zhang Z., Chen S.F., Bryers J.D., Jiang S.Y. Inhibition of Bacterial Adhesion and Biofilm Formation on Zwitterionic Surfaces. Biomaterials 2007, 28(29):4192-4199.
355. This paper gives an update on understanding of biocompatibility.
356. This is a comprehensive review about biological responses to biomaterials.
357. This review presents strategies of triggering appropriate immune response by functional biomaterials and highlights recent approaches of food biomaterials that mimic the physiological extracellular matrix.
358. This study is a demonstration about biomedical device-related infection.
359. This paper provides a markedly improved understanding of mechanisms of biocompatibility.
360. In this paper, progress of hemocompatible coatings was reviewed.
361. This review shows that the consensus biochemical mechanism of contact activation of blood-plasma coagulation that has long served as a rational for poor hemocompatibility is an inadequate basis for surface engineering of advanced cardiovascular biomaterials.
362. This is an FDA standard for blood-contacting biomedical devices.
363. This paper discusses the role of surface energy in the blood coagulation cascade.
364. This paper gives a detailed discussion about platelet activation.
365. This review presents models for biomaterial-induced activation processes and describes various strategies.
366. This paper discusses the new technologies that are being developed to shield the biomaterial and cell surfaces from recognition by the innate immune system.
367. This paper discusses the progress of nonthrombogenic therapeutics and the relevant mechanisms.
368. This paper discusses the role of surface hydration in providing nonfouling properties to different nonfouling materials.
369. In parallel to experimental studies, this is a modeling investigation to explain protein-repellent properties.
370. A comprehensive review about PEG application in biomedical field.
371. This work discusses the progress, synthesis method, mechanism and application of zwitterionic materials.
372. This paper gives a brief overview of heparan sulfate and its functions.
373. This paper gives a brief overview of thrombomodulin and its functions.
374. This paper gives a brief overview of nitric oxide and its antiplatelet function.
375. This paper gives a comprehensive discussion of heparin used as an anticoagulant.
376. This paper discusses the anticoagulant properties of antithrombin-heparin, an alternative of heparin.
377. This is a comprehensive review about engineering immunomodulatory materials.
378. This is a comprehensive review about antibacterial coatings.
379. This paper proposed a bactericidal mechanism for Ag-doped titanium.
380. This review discusses the implant-associated infections induced by Gram-positive staphylococci and gives a summary of the methods used to prevent this type of infection.
381. This paper synthesized a dual-functional coating which showed high bactericidal efficacy.